期刊文献+

祛风化湿健脾疏肝法对肠易激综合征大鼠模型5-HT,VIP水平的影响 被引量:2

Influences of Dispelling Wind-evil Dissipating Dampness and Strengthening Spleen Soothing Liver for 5-HT and VIP of Diarrhea Irritable Bowel Syndrome Rats
下载PDF
导出
摘要 目的:探讨祛风化湿健脾疏肝法对肠易激综合征大鼠模型5-HT,VIP水平的影响。方法:将实验大鼠分为4组:正常对照组(A组)、模型组(B组)、低剂量组(D组)、高剂量组(E组),每组各10只。A组和B组灌胃给予0.9%生理盐水10 mL/kg,D组和E组分别灌胃给予祛风化湿健脾疏肝组方10 mL(15 g)/kg和10 mL(30 g)/kg,均连续给药30 d,1次/d。观察5-羟色胺(5-HT)、血管活性肠肽(VIP)的含量。结果:与模型组相比,各给药组大鼠行为学和电生理指标均有明显改善;各给药组模型大鼠5-HT含量明显回落,VIP含量增加,并呈现一定的量效关系。结论:祛风化湿健脾疏肝法可能是通过降低模型大鼠血清5-HT、增加血浆VIP含量,减弱背角神经元兴奋性,提高内脏痛阈,消除肠道过敏,从而达到治疗肠易激综合征目的。 Objective:To explore the influences of dispelling wind-evil dissipating dampness and strengthening spleen soothing liver for diarrhea irritable bowel syndrome rats.Methods:Divided 50 rats into five group: control group(group A),model group(group B),composing prescriptions low-dose group(group D),composing prescriptions high-dose group(group E),10 cases in each group.Group A and B were treated with 0.9% normal saline,ig.;and group D and E were treated with composing prescriptions 10 ml(15 g)/kg and 10 ml(30 g)/kg respectively for 30 days and once each day. Then we investigate the content of 5 - HT and VIP. Results : Compared with model group, the indexes of behavior and electrophysiology for treated group were improved obviously, and the content of 5 - HT was reduced while the VIP was increased. The treated groups turned out dose - effect relationship. Conclusions : The composing prescrip- tions of dispelling wind - evil dissipating dampness and strengthening spleen soothing liver could through the mechanism of reducing 5 -HT, increasing VIP, weakening the dorsal horn neurons excitability and improving visceral pain domain, eliminating intestinal allergic to treat IBS.
出处 《航空航天医药》 2009年第12期32-33,89,共3页 Aerospace Medicine
基金 苏州昆山科技局课题(项目编号KS0621)
关键词 肠易激综合征 5-羟色胺 血管活性肠肽 Diarrhea irritable bowel syndrome 5-HT VIP
  • 相关文献

参考文献8

  • 1Read NW. Irritable bowel syndrome. In: M Feldman, LS Friedman, MH Sleisenger, editors. Gastrointestinal and liver disease. Philadelphia : Saunders ,2002 : 1794 - 804.
  • 2A1 - chaer ED, kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats by colon irritation during postnatal development [ J ]. Gastroenterology, 2000,199:1 276 - 1 285.
  • 3张秀明,顾仁骏,张中兴,尹景岗,柴建开.血清5-羟色胺的快速荧光测定法[J].上海医学检验杂志,1994,9(1):21-22. 被引量:15
  • 4Gue M, Lacheze C, Eutamene H, et al. Stress induced visceral hypersensitivity to rectal distension in rats:role of CRF andmas tcells [ J ]. Neurogastroenterol Motil, 1997,9 : 271 - 279.
  • 5詹丽杏,许国铭,李兆申,邹多武,金震东,屠振兴.肠易激综合征患者活动期和缓解期血浆5-HT、5-HIAA的变化[J].第二军医大学学报,2003,24(2):152-154. 被引量:33
  • 6李兆申,詹丽杏,邹多武,许国铭,满晓华,叶熙亭.肠易激综合征患者分泌5-羟色胺的肠嗜铬细胞形态及功能的改变[J].中华消化杂志,2004,24(2):94-97. 被引量:68
  • 7Park JH, Rhee PL, Kim G, et al. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea - predominant irritable bowel syndrome [ J ]. Neurogastroenterol Motil. 2006, 18 (7) :559 - 546.
  • 8Evangelista S. Involvement of tachykinin in intestinal inflammation [ J ]. Curr Pharm Des,2001,7 ( 1 ) : 19 - 30.

二级参考文献19

  • 1唐爱国,吴轰,高洁生,杨锡兰.高效液相色谱-电化学检测法同时测定血浆中5-羟色胺和5-羟吲哚乙酸[J].色谱,1995,13(6):472-475. 被引量:14
  • 2Heateon KW, O' Donnell LD, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology, 1992,102: 1962-1967.
  • 3Ferguson A, Sircus W, Eastwood MA. Frequency of functional gastrointestinal disorders. Lancet, 1977,2:613-614.
  • 4Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet, 1983,1: 632-634.
  • 5Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhea predominant irritable bowel syndrome:a pilot study. Gut, 1998,42:42-46.
  • 6Thompson WG. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Jalley NJ, eds. Functional gastrointestinal disorders: Rome Ⅱ . Mclean Virginia: Dgnon and Associates,2000. 360-382.
  • 7Miura M, Lawson DC, Clary EM, et al. Central modulation of rectal distension induced blood pressure changes by alosetron , a 5 HT3 receptor antagonist. Dig Dis Sci, 1999,44: 20-24.
  • 8Kozlowski CM, Green AN, Grundy D, et al. The 5-HT3 receptor antagonist alosetron inhibits the colorectal distention induced de pressor response and spinal c-fos expression in the anaesthetised rat. Gut, 2000,46: 474-480.
  • 9Kuemmerle JF, Murthy KS, Grider JR, et al. Coexpression of 5HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology, 1995, 109:1791-1800.
  • 10Tack J, Coulie B, Wilmer A, et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut, 2000, 46:468-473.

共引文献106

同被引文献40

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部